fda compounding glp-1 enforcement news november 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of medications like semaglutide and tirzepatide, signaling a major shift in how these FDA issued 25 warning letters

Eye exams recommended before and during treatment The AOA advises patients to undergo a comprehensive, dilated eye exam either within the year prior to starting a GLP-1 drug or within one month of beginning therapy

CMS continues to encourage individuals not to submit duplicative comments

The FcRn receptor is the primarily responsible for the protecting of IgG from catabolic activity in the body

A 45-year-old man in China who developed a large, dark discoloration of his upper gums had a rare type of melanoma, a cancer that usually happens on the skin, according to a new report of his case

How Soon Will I Feel Less Tired after A B12 Injection